Sage Therapeutics, Inc.
SAGE
$6.75
$0.192.90%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 423.85M | 504.42M | 569.15M | 646.79M | 717.01M |
| Total Receivables | 13.43M | 12.93M | 18.07M | 9.94M | 10.51M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 17.19M | 13.95M | 16.43M | 28.74M | 26.59M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 1.33M | 1.33M | 1.33M |
| Total Current Assets | 454.48M | 531.30M | 604.99M | 686.81M | 755.44M |
|
|
|||||
| Total Current Assets | 454.48M | 531.30M | 604.99M | 686.81M | 755.44M |
| Net Property, Plant & Equipment | 11.14M | 11.64M | 12.27M | 2.49M | 4.44M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.06M | 4.28M | 5.18M | 7.80M | 7.72M |
| Total Assets | 469.67M | 547.22M | 622.43M | 697.11M | 767.60M |
|
|
|||||
| Total Accounts Payable | 5.44M | 12.70M | 7.13M | 8.65M | 6.48M |
| Total Accrued Expenses | 35.75M | 42.29M | 53.05M | 58.22M | 49.45M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.81M | 1.32M | 83.00K | 1.41M | 3.31M |
| Total Finance Division Other Current Liabilities | 6.78M | 15.31M | 152.00K | 762.00K | 2.57M |
| Total Other Current Liabilities | 6.78M | 15.31M | 152.00K | 762.00K | 2.57M |
| Total Current Liabilities | 49.78M | 71.62M | 60.41M | 69.04M | 61.80M |
|
|
|||||
| Total Current Liabilities | 49.78M | 71.62M | 60.41M | 69.04M | 61.80M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 10.04M | 10.52M | 10.19M | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 59.82M | 82.13M | 70.60M | 69.04M | 61.80M |
|
|
|||||
| Common Stock & APIC | 3.44B | 3.44B | 3.43B | 3.41B | 3.39B |
| Retained Earnings | -3.03B | -2.97B | -2.87B | -2.78B | -2.68B |
| Treasury Stock & Other | -258.00K | -156.00K | 501.00K | -1.09M | -1.19M |
| Total Common Equity | 409.85M | 465.09M | 551.84M | 628.06M | 705.80M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 409.85M | 465.09M | 551.84M | 628.06M | 705.80M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 409.85M | 465.09M | 551.84M | 628.06M | 705.80M |
|
|
|||||